Eugene Maxwell

674 total citations
6 papers, 349 citations indexed

About

Eugene Maxwell is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Eugene Maxwell has authored 6 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Cancer Research. Recurrent topics in Eugene Maxwell's work include Cancer-related Molecular Pathways (3 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Protein Kinase Regulation and GTPase Signaling (1 paper). Eugene Maxwell is often cited by papers focused on Cancer-related Molecular Pathways (3 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Protein Kinase Regulation and GTPase Signaling (1 paper). Eugene Maxwell collaborates with scholars based in United Kingdom. Eugene Maxwell's co-authors include W. Robert Bishop, Mark J. Demma, Bimalendu Dasmahapatra, Ronald J. Doll, Yan Wang, Jonathan A. Pachter, Kimberly Gray, Hena R. Ashar, Donna Carr and Arthur G. Taveras and has published in prestigious journals such as Journal of Biological Chemistry, Experimental Cell Research and PubMed.

In The Last Decade

Eugene Maxwell

6 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eugene Maxwell United Kingdom 5 269 179 56 51 46 6 349
Gillian N. Kulikowski United States 8 231 0.9× 187 1.0× 39 0.7× 72 1.4× 20 0.4× 9 354
Jessica Ekedahl Sweden 8 299 1.1× 103 0.6× 23 0.4× 49 1.0× 42 0.9× 8 384
Michael W. Potter United States 9 290 1.1× 179 1.0× 17 0.3× 70 1.4× 12 0.3× 10 400
Margaret LaCava United States 11 309 1.1× 227 1.3× 13 0.2× 65 1.3× 17 0.4× 14 445
James Zweibel United States 8 258 1.0× 123 0.7× 40 0.7× 70 1.4× 5 0.1× 10 370
Sofya Rodov United States 11 253 0.9× 214 1.2× 12 0.2× 74 1.5× 9 0.2× 12 463
Megan B. Salt United States 4 302 1.1× 151 0.8× 14 0.3× 73 1.4× 8 0.2× 4 412
Elizabeth Moskatel United States 3 318 1.2× 96 0.5× 7 0.1× 44 0.9× 25 0.5× 4 389
Astrid Balkenende Netherlands 5 274 1.0× 237 1.3× 17 0.3× 85 1.7× 10 0.2× 6 442
Florence Giffard France 13 320 1.2× 90 0.5× 11 0.2× 173 3.4× 20 0.4× 23 454

Countries citing papers authored by Eugene Maxwell

Since Specialization
Citations

This map shows the geographic impact of Eugene Maxwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugene Maxwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugene Maxwell more than expected).

Fields of papers citing papers by Eugene Maxwell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugene Maxwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugene Maxwell. The network helps show where Eugene Maxwell may publish in the future.

Co-authorship network of co-authors of Eugene Maxwell

This figure shows the co-authorship network connecting the top 25 collaborators of Eugene Maxwell. A scholar is included among the top collaborators of Eugene Maxwell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugene Maxwell. Eugene Maxwell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Demma, Mark J., Eugene Maxwell, Robert Ramos, et al.. (2010). SCH529074, a Small Molecule Activator of Mutant p53, Which Binds p53 DNA Binding Domain (DBD), Restores Growth-suppressive Function to Mutant p53 and Interrupts HDM2-mediated Ubiquitination of Wild Type p53. Journal of Biological Chemistry. 285(14). 10198–10212. 83 indexed citations
2.
Demma, Mark J., et al.. (2004). CP-31398 Restores DNA-binding Activity to Mutant p53 in Vitro but Does Not Affect p53 Homologs p63 and p73. Journal of Biological Chemistry. 279(44). 45887–45896. 53 indexed citations
3.
Jetzt, Amanda E., John A. Howe, Mark Horn, et al.. (2003). Adenoviral-mediated expression of a kinase-dead mutant of Akt induces apoptosis selectively in tumor cells and suppresses tumor growth in mice.. PubMed. 63(20). 6697–706. 47 indexed citations
4.
Maxwell, Eugene, et al.. (2002). Neutralizing anti-insulin-like growth factor receptor 1 antibodies inhibit receptor function and induce receptor degradation in tumor cells.. PubMed. 1(14). 1349–53. 73 indexed citations
5.
Ashar, Hena R., Linda James, Kimberly Gray, et al.. (2001). The Farnesyl Transferase Inhibitor SCH 66336 Induces a G2 → M or G1 Pause in Sensitive Human Tumor Cell Lines. Experimental Cell Research. 262(1). 17–27. 92 indexed citations
6.
King, I., C H Blood, Ming Chu, et al.. (1995). Antitumor effect of keto-diepoxides isolated from the fungus Nattrassia mangiferae.. PubMed. 7(1). 1–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026